Evogene Ltd Ordinary Shares (EVGN)
Stock · NASDAQ · Industrials
$0.39as of 10/16/2026
Price chart
EVGN Signal Track Record
How signals performed across all stocks →What EVGN's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 39 | -8.2% | 38% | September 29, 2026 |
| Bollinger Band Breakdown | 25 | -5.6% | 36% | September 21, 2026 |
| Bollinger Band Breakout | 18 | -8.6% | 39% | August 4, 2026 |
| 200-Day Moving Average TouchActive now | 10 | -10.3% | 30% | October 28, 2025 |
| Any 20-session window (baseline) | -6.3% | 33% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About EVGN
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a com…
- Sector
- Industrials
- Industry
- Agricultural Chemicals
- Employees
- 38
- Website
- evogene.com/
Fundamentals
- 1-day range
- $0.375$0.3999
- Market cap
- $9.08M
- P/E (trailing)
- —
- P/E (forward)
- -0.67
- EPS (trailing)
- $-0.91
- Dividend yield
- —
- Beta
- 1.42
- Avg. volume
- 1.45M
Forecasts
1 analyst ratings
Evogene Ltd Ordinary Shares Competitors
Chosen by industry and closest market cap.
- EVGNEvogene Ltd Ordinary Shares$0.39▼ 2.50%Market cap $9.08MP/E —$0.3521$1.49
- SNESSenesTech Inc. Common Stock$0.647▼ 7.44%Market cap $6.74MP/E —$0.6101$4.19
- FRTTFort Technology Inc. Common Shares$0.54▼ 10.00%Market cap $14.75MP/E —$0.6003$4.09
- NXTSNexentis Technologies Inc. Common Stock$0.645▼ 5.43%Market cap $2.80MP/E —$0.6$32.9
- BIOXBioceres Crop Solutions Corp. Ordinary Shares$0.276▼ 6.12%Market cap $22.76MP/E —$0.28$2.19
- AVDAmerican Vanguard Corporation Common Stock ($0.10 Par Value)$1.06▼ 15.20%Market cap $88.01MP/E —$1.13$5.55
- CBUSCibus Inc. Class A Common Stock$1.32▲ 2.33%Market cap $142.74MP/E —$1.09$4.19
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| EVGN Evogene Ltd Ordinary Shares | $9.08M | — | $0.39 | ▼ 2.50% | $0.3521$1.49 |
| SNES SenesTech Inc. Common Stock | $6.74M | — | $0.647 | ▼ 7.44% | $0.6101$4.19 |
| FRTT Fort Technology Inc. Common Shares | $14.75M | — | $0.54 | ▼ 10.00% | $0.6003$4.09 |
| NXTS Nexentis Technologies Inc. Common Stock | $2.80M | — | $0.645 | ▼ 5.43% | $0.6$32.9 |
| BIOX Bioceres Crop Solutions Corp. Ordinary Shares | $22.76M | — | $0.276 | ▼ 6.12% | $0.28$2.19 |
| AVD American Vanguard Corporation Common Stock ($0.10 Par Value) | $88.01M | — | $1.06 | ▼ 15.20% | $1.13$5.55 |
| CBUS Cibus Inc. Class A Common Stock | $142.74M | — | $1.32 | ▲ 2.33% | $1.09$4.19 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Wednesday's After-Market SessionBenzinga · 10/7/2026
- Evogene Reaches Agreement With Pure Capital Group To Resolve Differencesbenzinga · 10/6/2026
- Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of DirectorsYahoo · 10/6/2026
- Evogene Reaches Agreement With Pure Capital Group To Resolve DifferencesBenzinga · 10/6/2026
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 10/2/2026
- Unusual volume stocks in Wednesday's sessionChartMill · 9/30/2026
- Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price ComplianceYahoo · 9/30/2026
- Evogene Discloses That Another Nasdaq 180-Day Period For Regaining Minimum Bid Price Requirement Has Been Extended Until March 29, 2027Benzinga · 9/30/2026
- What's going on in today's after hours sessionChartMill · 9/29/2026
Insider Activity
Insider Actions →- Leon Recanati · August 11, 2026 · Buy460.0K @ $0.635
- Leon Recanati · August 4, 2026 · Buy800.0K @ $0.5
- Tarcic Gabi · June 4, 2026 · Buy1.1K @ $0.6
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Evogene gets 180-day extension for Nasdaq bid price compliance
Evogene announced that Nasdaq granted an additional 180-day period to regain compliance with the minimum bid price requirement. This extension allows the company until March 29, 2027, to meet the exchange's listing standards. The news highlights ongoing challenges for the stock, which has traded as low as $0.35 over the past year.
Evogene gets 180-day extension for Nasdaq bid price compliance. Evogene announced that Nasdaq granted an additional 180-day period to regain compliance with the minimum bid price requirement. This extension allows the company until March 29, 2027, to meet the exchange's listing standards. The news highlights ongoing challenges for the stock, which has traded as low as $0.35 over the past year.